NFKB1 and breast cancer: In a study it has been shown that melatonin could upregulate the NF-κB pathway proteins expression in hepatocarcinoma cells, but treatment of breast cancer cells with melatonin causes decrease in expression of NF-κB pathway proteins in them [117].